| Characteristic | Censored N = 2,1981 |
Death N = 881 |
Relapse N = 3141 |
p-value2 |
|---|---|---|---|---|
| Demographics | ||||
| Social Vulnerability mobility | 0.041 | |||
| Consistently low | 395 (18%) | 24 (27%) | 68 (22%) | |
| Consistently moderate | 389 (18%) | 9 (10%) | 48 (15%) | |
| Decreasing | 313 (14%) | 17 (19%) | 42 (13%) | |
| Increasing | 549 (25%) | 25 (28%) | 86 (27%) | |
| Consistently high | 552 (25%) | 13 (15%) | 70 (22%) | |
| Gender | >0.9 | |||
| Female | 956 (44%) | 38 (43%) | 133 (42%) | |
| Male | 1,241 (56%) | 50 (57%) | 181 (58%) | |
| Age at diagnosis (years) | <0.001 | |||
| 1-4 | 538 (24%) | 6 (6.8%) | 59 (19%) | |
| 5-9 | 909 (41%) | 20 (23%) | 132 (42%) | |
| 10-14 | 562 (26%) | 48 (55%) | 95 (30%) | |
| 15-21 | 189 (8.6%) | 14 (16%) | 28 (8.9%) | |
| Race/Ethnicity | 0.001 | |||
| Non-Hispanic White | 1,512 (69%) | 51 (58%) | 194 (62%) | |
| Non-Hispanic Black | 132 (6.0%) | 7 (8.0%) | 35 (11%) | |
| Hispanic (All races) | 392 (18%) | 25 (28%) | 67 (21%) | |
| Other | 162 (7.4%) | 5 (5.7%) | 18 (5.7%) | |
| Medical insurance provider | 0.060 | |||
| Private | 1,510 (69%) | 56 (64%) | 192 (61%) | |
| Public | 469 (21%) | 24 (27%) | 80 (25%) | |
| Other/Unknown | 219 (10.0%) | 8 (9.1%) | 42 (13%) | |
| Clinical characteristics | ||||
| ALL subtype | <0.001 | |||
| Standard-risk B-cell ALL | 1,124 (51%) | 12 (14%) | 127 (40%) | |
| High-risk B-cell ALL | 706 (32%) | 59 (67%) | 139 (44%) | |
| T-cell ALL | 368 (17%) | 17 (19%) | 48 (15%) | |
| WBC count at diagnosis | <0.001 | |||
| <50,000/ul | 1,818 (83%) | 53 (62%) | 222 (71%) | |
| >=50,000/ul | 375 (17%) | 33 (38%) | 92 (29%) | |
| CNS involvement | 0.053 | |||
| CNS1-2 | 2,149 (98%) | 83 (97%) | 302 (96%) | |
| CNS3 | 38 (1.7%) | 3 (3.5%) | 11 (3.5%) | |
| Cytogenetics | <0.001 | |||
| Favorable | 877 (40%) | 6 (6.8%) | 57 (18%) | |
| Neutral | 804 (37%) | 51 (58%) | 157 (50%) | |
| Unfavorable | 149 (6.8%) | 14 (16%) | 52 (17%) | |
| Missing | 368 (17%) | 17 (19%) | 48 (15%) | |
| P values: Pearson chi-square (no continuity correction) for categorical variables; Fisher’s exact test for CNS group (sparse counts). Missing data (not shown in table; excluded from p-values per variable): cns_grp=14; wbc_cat=7; sex=1. | ||||
| 1 n (%) | ||||
| 2 Pearson’s Chi-squared test | ||||